Tilaknagar Industries Ltd Board Approves Unaudited Financial Results for Q3 FY26
Tilaknagar Industries Ltd. announced that its Board of Directors approved the Unaudited Financial Results (Consolidated and Standalone) for…
Torrent Pharma Announces Q3 FY26 Results with 26% YoY Net Profit Growth and JB Chemicals Acquisition Integration
Torrent Pharmaceuticals declared its Q3 FY26 financial results on February 13, 2026, reporting robust performance driven by its branded…
RHI Magnesita India Reports Strong Q3 FY26 Performance Driven by Steel Sector Recovery and Strategic Wins
RHI Magnesita India Limited announced robust financial results for the third quarter of the fiscal year ending December 31, 2025. Revenue from…
Jindal Worldwide Limited Board Approves Unaudited Financial Results for Q3 FY2025-26
The Board of Directors of Jindal Worldwide Limited met on February 13, 2026, to approve the Unaudited Financial Results for the quarter and…
IRB Infrastructure Developers Ltd Corporate Presentation Filed for Quarter Ended December 31, 2025
IRB Infrastructure Developers Ltd has officially released its Corporate Presentation covering the financial performance and operational…
IHCL Disclosure of Additional Penalty Claim on Property Taxes for Taj Lands End, Mumbai
The Indian Hotels Company Limited (IHCL) has reported receiving an additional penalty claim of Rs. 4,29,02,720/- from the Brihanmumbai…
Colgate-Palmolive (India) Limited Launches New Campaign Featuring Kriti Sanon and Abhishek Sharma for Visible White Purple
Colgate-Palmolive (India) Limited announced the launch of its latest multi-platform campaign for Colgate Visible White Purple on February 13,…
L&T Finance Announcement of Call Option Exercise for Subordinated Perpetual Debt Instruments
L&T Finance Limited has decided to exercise the call option on its Subordinated Perpetual Tier – I Debt (NCDs) originally issued by…
RHI Magnesita India Ltd Board Approves Unaudited Q3 FY26 Financial Results
The Board of Directors of RHI Magnesita India Ltd. convened on February 13, 2026, approving the Unaudited Consolidated and Standalone…
Torrent Pharma Analyst Presentation on Unaudited Financial Results for Q3 FY 2025-26
Torrent Pharmaceuticals announced the release of its presentation materials for analysts covering the unaudited Consolidated Financial Results…